🇺🇸 FDA
Patent

US 11219643

Compositions for cellular restoration and methods of making and using same

granted A61KA61K35/12A61K35/15

Quick answer

US patent 11219643 (Compositions for cellular restoration and methods of making and using same) held by Advanced ReGen Medical Technologies, LLC expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Advanced ReGen Medical Technologies, LLC
Grant date
Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K35/12, A61K35/15, A61K38/18, A61P